381 related articles for article (PubMed ID: 24183231)
21. Thromboembolism in inflammatory bowel disease: an insidious association requiring a high degree of vigilance.
Di Fabio F; Lykoudis P; Gordon PH
Semin Thromb Hemost; 2011 Apr; 37(3):220-5. PubMed ID: 21455856
[TBL] [Abstract][Full Text] [Related]
22. Risk of arterial thrombotic events in inflammatory bowel disease.
Ha C; Magowan S; Accortt NA; Chen J; Stone CD
Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
[TBL] [Abstract][Full Text] [Related]
23. Intra-abdominal venous and arterial thromboembolism in inflammatory bowel disease.
Di Fabio F; Obrand D; Satin R; Gordon PH
Dis Colon Rectum; 2009 Feb; 52(2):336-42. PubMed ID: 19279432
[TBL] [Abstract][Full Text] [Related]
24. Thromboembolic complications in inflammatory bowel disease.
Kohoutova D; Moravkova P; Kruzliak P; Bures J
J Thromb Thrombolysis; 2015 May; 39(4):489-98. PubMed ID: 25115840
[TBL] [Abstract][Full Text] [Related]
25. Thromboembolic events in patients with inflammatory bowel disease.
Algahtani FH; Farag YM; Aljebreen AM; Alazzam NA; Aleem AS; Jabri FF; Rajab MH; Shoukri MM
Saudi J Gastroenterol; 2016 Nov; 22(6):423-427. PubMed ID: 27976637
[TBL] [Abstract][Full Text] [Related]
26. A nationwide survey concerning the mortality and risk of progressing severity due to arterial and venous thromboembolism in inflammatory bowel disease in Japan.
Ando K; Fujiya M; Watanabe K; Hiraoka S; Shiga H; Tanaka S; Iijima H; Mizushima T; Kobayashi T; Nagahori M; Ikeuchi H; Kato S; Torisu T; Kobayashi K; Higashiyama M; Fukui T; Kagaya T; Esaki M; Yanai S; Abukawa D; Naganuma M; Motoya S; Saruta M; Bamba S; Sasaki M; Uchiyama K; Fukuda K; Suzuki H; Nakase H; Shimizu T; Iizuka M; Watanabe M; Suzuki Y; Hisamatsu T
J Gastroenterol; 2021 Dec; 56(12):1062-1079. PubMed ID: 34611740
[TBL] [Abstract][Full Text] [Related]
27. The increasing incidence of thromboembolic events among hospitalized patients with inflammatory bowel disease.
Kuy S; Dua A; Chappidi R; Seabrook G; Brown KR; Lewis B; Rossi PJ; Lee CJ
Vascular; 2015 Jun; 23(3):260-4. PubMed ID: 24986868
[TBL] [Abstract][Full Text] [Related]
28. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease.
Novacek G; Miehsler W; Kapiotis S; Katzenschlager R; Speiser W; Vogelsang H
Am J Gastroenterol; 1999 Mar; 94(3):685-90. PubMed ID: 10086652
[TBL] [Abstract][Full Text] [Related]
29. Thromboembolic Events in Hospitalized Patients with Inflammatory Bowel Disease.
Nelson AD; Fluxá D; Caldera F; Farraye FA; Hashash JG; Kröner PT
Dig Dis Sci; 2023 Jun; 68(6):2597-2603. PubMed ID: 37027107
[TBL] [Abstract][Full Text] [Related]
30. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Wajda A; Blanchard JF
Clin Gastroenterol Hepatol; 2008 Jan; 6(1):41-5. PubMed ID: 18063423
[TBL] [Abstract][Full Text] [Related]
31. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis.
Singh S; Singh H; Loftus EV; Pardi DS
Clin Gastroenterol Hepatol; 2014 Mar; 12(3):382-93.e1: quiz e22. PubMed ID: 23978350
[TBL] [Abstract][Full Text] [Related]
32. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study.
Grainge MJ; West J; Card TR
Lancet; 2010 Feb; 375(9715):657-63. PubMed ID: 20149425
[TBL] [Abstract][Full Text] [Related]
33. Venous thrombotic events in hospitalized children and adolescents with inflammatory bowel disease.
Nylund CM; Goudie A; Garza JM; Crouch G; Denson LA
J Pediatr Gastroenterol Nutr; 2013 May; 56(5):485-91. PubMed ID: 23232326
[TBL] [Abstract][Full Text] [Related]
34. Systemic thromboembolism in inflammatory bowel disease: mechanisms and clinical applications.
Twig G; Zandman-Goddard G; Szyper-Kravitz M; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1051():166-73. PubMed ID: 16126956
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of lower extremity venous disease in inflammatory bowel disease.
Gosk-Bierska I; McBane RD; Waszczuk E; Paradowski L; Wysokinski WE
Int Angiol; 2007 Mar; 26(1):67-71. PubMed ID: 17353891
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis.
Dorn SD; Sandler RS
Am J Gastroenterol; 2007 Mar; 102(3):662-7. PubMed ID: 17156143
[TBL] [Abstract][Full Text] [Related]
37. Risk of catheter-associated deep venous thrombosis in inflammatory bowel disease.
Bhakta A; Tafen M; Ahmed M; Ata A; Abraham C; Bruce D; Valerian BT; Lee EC
Dis Colon Rectum; 2014 Dec; 57(12):1379-83. PubMed ID: 25380003
[TBL] [Abstract][Full Text] [Related]
38. Increased risk of postoperative deep vein thrombosis and pulmonary embolism in patients with inflammatory bowel disease: a study of National Surgical Quality Improvement Program patients.
Merrill A; Millham F
Arch Surg; 2012 Feb; 147(2):120-4. PubMed ID: 22006853
[TBL] [Abstract][Full Text] [Related]
39. Venous and arterial thromboembolism in patients with inflammatory bowel diseases.
Stadnicki A; Stadnicka I
World J Gastroenterol; 2021 Oct; 27(40):6757-6774. PubMed ID: 34790006
[TBL] [Abstract][Full Text] [Related]
40. Is there a cardiovascular risk in inflammatory bowel diseases?
Mitu O; Alexandrescu DM; Cătălina M; Cristina CP
Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):918-23. PubMed ID: 25581948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
